Oscotec - Crunchbase Company Profile & Funding

Q: Where is Oscotec's headquarters?

Oscotec is located in Seongnam, Kyonggi-do, South Korea.

Overview

Oscotec

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Oscotec

CB Rank

412052

Oscotec specializes in research and development of human health.

Founded

obfuscation

Public

Seongnam, Kyonggi-do, South Korea

11-50

www.oscotec.com

Biotechnology

Health Care

Medical

Key People

James Kim: Founder and CEO

Details

Legal Name

Oscotec Inc.

Also Known As

오스코텍

Operating Status

Active

Stock Symbol

KOSDAQ:039200

Company Type

For Profit

Founders

James Kim

About the Company

Oscotec creates value by translating cutting-edge science into innovative medicines for clinically unmet needs. They provide a clinical-stage drug discovery and development company. For inquiries, telephone and contact numbers are used.

Phone Number

+82 31 628 7630

Predictions & Insights

Growth Insight

See this Growth Insight

Oscotec is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

SKI-O-703 (SYK inhibitor)

An oral SYK inhibitor in Phase 2 trials for rheumatoid arthritis and immune thrombocytopenia, targeting patients non-responsive to existing treatments.

Lazertinib (EGFR inhibitor)

A third-generation EGFR inhibitor approved for non-small cell lung cancer patients with T790M mutation resistant to earlier EGFR inhibitors.